Stay updated with breaking news from Matt erick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
International Business News: NEW DELHI: Biocon Biologics announced that the US Food and Drug Administration (US FDA) has approved the company's application for YESAFILI, the compa. ....
Sandoz will get the exclusive rights to promote, sell, and distribute Trastuzumab and Bevacizumab, which are used in the treatment of various cancers, in Australia ....
Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced a five-year partnership with Sandoz AG ('Sandoz') which provides Sandoz the exclusive rights to promote, sell and distribute biosimilar Trastuzumab (market value of AUD$35 million1) and biosimilar Bevacizumab (market value of AUD$45 million2) in Australia. ....
Biocon subsidiary partners with Sandoz Australia - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.